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Modulatory influences on sympathetic nervous system activity are diverse and far reaching, 
acting at select points in the complex pathways controlling sympathetic outflow to enable subtle 
changes or more global effects. Changes in the degree of sympathetic neuromodulation can 
have serious consequences on homeostatic variables such as heart rate, blood pressure and 
gut motility. At the level of the spinal cord, the sympathetic preganglionic neurons (SPNs) can 
be modulated by activation of presynaptic GABAB heteroreceptors on glutamatergic terminals 
and by postsynaptic GABAB receptors. Here we show that a low concentration of the GABAB 
agonist baclofen (1 μM) attenuated GABAergic inhibitory postsynaptic potentials in SPNs elicited 
from stimulation of either the central autonomic area or descending fibers in the lateral funiculus. 
This low baclofen concentration also elicited three categories of postsynaptic response: a 
large hyperpolarization with a decrease in input resistance, a moderate hyperpolarization with 
no change in input resistance and no response. Using cesium-loaded, tetraethylammonium 
chloride containing electrodes (to block potassium conductance), baclofen elicited moderate 
hyperpolarizations with no change in input resistance in 50% of SPNs; the remainder were 
unaffected. These modest hyperpolarizations were reduced in Ca2+ free solution or cadmium. 
Hyperpolarizing responses were also observed in interneurons in the vicinity of SPNs. These 
studies provide the first evidence for GABAB autoreceptors involved in inhibitory GABAergic 
transmission onto SPNs and for postsynaptic GABAB receptors on interneurons. The data also 
indicate that there is heterogeneity in the postsynaptic responses of SPNs.
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GABA
B
 receptors, like adenosine receptors, are also important 
modulators of neuronal excitability (Kerr and Ong, 1995). Their 
widespread actions and involvement in mechanisms underlying 
pathologies such as epilepsy and chronic pain (Bowery, 2006) have 
led to an increased interest in regulating these receptors as potential 
therapeutic targets. GABA
B
 receptors are present postsynaptically 
on SPNs and high concentrations of the GABA
B
 agonist, baclofen 
(10–100 μM) elicited hyperpolarizing responses associated with 
a decrease in input resistance that was attributed to opening of 
potassium channels (Whyment et al., 2004). However, a proportion 
of these responses may be due to activation of other second mes-
senger mediated channels since in splanchnic SPNs, 5 μM baclofen 
also increased potassium channel opening but with an accompany-
ing decrease in voltage gated calcium conductance, that together 
caused inconsistent effects on input resistance (Cheng et al., 2005). 
These discrepancies in findings regarding the nature of postsynaptic 
GABA
B
 mediated responses may be due to differences in concentra-
tion of baclofen used.
Presynaptic GABA
B
 heteroreceptors have been reported on exci-
tatory terminals onto SPNs by Cheng’s group and others (Cheng 
et al., 2005; Wu and Dun, 1992). Here applications of baclofen 
(1–30 μM) decreased excitatory amino acid mediated transmis-
sion from lateral funiculus (Lf) stimulation (which comprises 
descending inputs to SPNs) although Wu and Dun (1992) reported 
that baclofen was without effect on the postsynaptic membrane. 
IntroductIon
Sympathetic outflow to the many organs controlled by the auto-
nomic nervous system is regulated at a number of levels within 
the central nervous system. The final point at which sympathetic 
activity can be influenced by the CNS is at the spinal cord level 
where the sympathetic preganglionic neurons (SPNs) reside. 
Continuing research into the spinal cord circuitry that regulates 
sympathetic output has revealed a high degree of complexity of 
control of these SPNs which enables fine tuning of the sympa-
thetic activity influencing end organs. For example, studies from 
our laboratory have revealed that at least two GABAergic inhibi-
tory influences on SPNs exist; one a descending monosynaptic 
inhibitory influence originating in the brainstem (Deuchars et al., 
1997; Deuchars et al., 2001a) and another more local input from 
GABAergic interneurons located in the central autonomic area 
of the spinal cord (Deuchars et al., 2005). Thus one avenue for 
selective regulation of SPN activity would be at a presynaptic level 
since receptors located on specific presynaptic terminals would 
influence synaptic transmission exclusively from that input. Such 
input-specific modulation is observed in SPNs where A1 adenos-
ine receptors are located on excitatory terminals and their activa-
tion decreases excitatory transmission (Deuchars et al., 2001a) 
whilst A2A adenosine receptors are confined solely to inhibitory 
GABAergic terminals and increase GABAergic transmission 
(Brooke et al., 2004).
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Responses to bath applied drugs were determined. Neurons were 
held at −60 mV (not corrected for liquid junction potentials) to 
test the effects of the GABA
B
 agonist baclofen and hyperpolarizing 
current pulses of −10 to −50 pA (1 s duration) injected to monitor 
changes in input resistance, represented by a change in the size of 
the voltage response to the injected current. Baclofen was repeat-
edly applied and during a response, the membrane potential was 
returned to −60 mV to check that the change in input resistance was 
due to an effect of the drug and not the voltage induced changes. To 
confirm that changes in membrane potential and input resistance 
were due to a specific action of the agonist at the GABA
B 
receptor, 
the selective antagonist CGP55845 was applied for ≥5 to 10 min 
prior to application of the agonist.
The central autonomic area and the Lf were stimulated using 
bipolar stimulating electrodes and isolated stimulators (DS2A; 
Digitimer, Hertfordshire, UK). IPSPs were elicited at more depo-
larized potentials (−10 to +10 mV) to increase the chloride driv-
ing force. Paired pulse stimuli were used to investigate presynaptic 
actions of pharmacological tools.
Drugs, a GABA
B
 agonist baclofen and an antagonist CGP55845 
(both from Tocris Cookson, Bristol, UK), were applied in the super-
fusing solution and the concentration given is the final concentra-
tion in the bath. Both drugs were first dissolved in DMSO and the 
final concentration of DMSO in the bath was less than 1:1000. 
Bicuculline hydrochloride (Tocris Cookson) and cadmium chloride 
(Sigma, UK) were dissolved in water.
data analysIs
Data capture was carried out using either Signal (version 1) and 
Spike 2 (version 2; Cambridge Electronic Design) or pClamp (ver-
sion 9, Axon Instruments). The input resistance was calculated for 
each neuron by measurement of the voltage responses to injected 
current pulses (average of 3 sweeps). IPSP amplitudes were calcu-
lated by measuring their peak amplitude from the holding potential 
and were averaged for ≥10 consecutive sweeps and are given as the 
mean ± SEM.
Changes in IPSP amplitude as a consequence of drug appli-
cation were expressed as a mean percentage of the control. 
Assessment of changes in the paired pulse ratio (PPR) was also 
carried out. PPR was derived from the ratio of the amplitude of 
the second IPSP to the first IPSP. The PPR during drug applica-
tion was then compared with the control to note any significant 
change. The effects of the drugs were tested statistically using the 
paired Student’s t-test, and differences were considered significant 
when p < 0.05.
rna extractIon and Pcr
Total RNA was isolated from micropunches of IML and spinal 
cord slices of rats (10–15 days), anesthetized and prepared as 
described above. The RNA was reverse transcribed as previously 
described (Spary et al., 2008). PCR was performed with 0.4 μM 
primers (GABA
B1a
 forward 5′-TAGCGATCGAGAAGGGGAGA-3′; 
GABA
B1a
 reverse 5′-CTTCACCTGGTCGCGAGTCA-3′; GABA
B1b
 
forward 5′-GCGAACGTCTCCTGGCCCTA-3′; GABA
B1b
 
reverse 5′-GCGGGAGATGAGGGGAGTGA-3′; GABA
B2
 for-
ward 5′-AGCAGATCCGCAACGAGTCA-3′; GABA
B2
 reverse 
5′-GTGCTTCAGGAGCTTCAGGA-3′) (Spary et al., 2008).
However, to date no evidence exists of GABAB autoreceptors on 
descending or local inhibitory inputs onto SPNs. Such autorecep-
tors are common in other regions of the CNS and may display 
different pharmacological profiles to heteroreceptors (Bonanno 
and Raiteri, 1992). In fact, differences in the sensitivity of pre versus 
postsynaptic receptors to baclofen are also common findings – in 
neurons of the nucleus tractus solitarius, among others, the sensitiv-
ity of presynaptic receptors was at least 20-fold higher than that of 
the postsynaptic receptors (Brooks and Glaum, 1995).
The lack of data regarding a role for GABA
B
 autoreceptors in spi-
nal cord circuitry underlying sympathetic control led us to examine 
how GABA
B
 receptors may affect synaptic inhibitory transmission 
from both descending and local inputs onto SPNs. Furthermore the 
intriguing possibility of GABA
B
 receptors with specific sensitivities 
to baclofen prompted us to determine how very low concentrations 
of baclofen affects both pre- and postsynaptic GABA
B
 receptors on 
SPNs in the thoracic spinal cord slice preparation.
MaterIals and Methods
Patch claMP recordIngs
All experiments were performed under UK Home Office License 
and in accordance with the regulations of the UK Animals (Scientific 
Procedures) Act 1986.
Wistar rats of either sex aged 10–15 days were anesthetized with 
urethane (2 g/kg, i.p.) and transcardially perfused with ice-cold 
sucrose aCSF, composition (in mM); sucrose (217), NaHCO
3
 (26), 
KCl (3), MgSO
4
 (2), NaH
2
PO
4
 (2.5), CaCl
2
 (1), and glucose (10). 
After decapitation, the upper and middle thoracic spinal cord was 
isolated and the dura and pia mater were carefully removed. Coronal 
slices of 300 μm were cut using a Vibroslice (Campden Instruments) 
and kept in a holding chamber containing aCSF, composition (in 
mM): NaCl (124), NaHCO
3
 (26), KCl (3), MgSO
4
 (2), NaH
2
PO
4
 
(2.5), CaCl
2
 (2), and glucose (10), bubbled in 95% O
2
/5%CO
2
.
Slices were transferred to a submerged recording chamber and 
continually perfused with aCSF also containing the non-selective 
glutamate receptor antagonist kynurenic acid (2 mM) at a rate of 
2–5 ml/min at room temperature. For experiments carried out in 
calcium-free aCSF, CaCl
2
 was replaced with 2 mM MgCl
2
. Whole-
cell patch clamp recordings were made in current-clamp mode 
using an Axopatch 1D (Axon Instruments, Foster City, CA, USA). 
Patch electrodes (tip diameter, 3 μm; resistance 3–6 MΩ) were 
filled with either K-Gluconate based intracellular solution, compo-
sition (in mM): K-Gluconate (110), EGTA (11), MgCl
2
 (2), CaCl
2
 
(0.1), HEPES (10), Na
2
ATP (2), and NaGTP (0.3); or Cs-based 
intracellular solution, composition (in mM): Cs
2
SO
4
 (110), CaCl
2
 
(0.5), MgCl
2
 (2), EGTA (5), HEPES (5), ATP-Na
2
 (5), TEA (5). 
Liquid junction potentials (14.8 mV for K-Gluconate intracellu-
lar; 10.9 mV for Cs
2
SO
4
 intracellular) were not corrected for in 
these experiments.
Neurons (SPNs and interneurons) within the IML were iden-
tified both electrophysiologically and anatomically as described 
previously (Deuchars et al., 2001b). When using Cs-based intra-
cellular solution, the electrophysiological properties of the two 
populations were less prominent but their distinctive morphology 
still enabled identification post hoc. Depolarizing current pulses 
of +10 to +200 pA were applied to examine firing properties of 
the neurons.
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Negative controls included dH
2
O and RNA, which had not 
undergone reverse transcription. The veracity of the PCR products 
was confirmed by DNA sequencing on an ABI 3100 genetic analyzer 
using BigDye terminator cycle sequencing version 3.1.
results
PostsynaPtIc effects of low concentratIons of baclofen 
recorded In K-gluconate based Intracellular solutIon
Firstly we determined how a low concentration of the GABA
B
 recep-
tor agonist baclofen affected postsynaptic responses of SPNs, using a 
concentration (1 μM) that has previously been shown in the nucleus of 
the tractus solitarius to selectively target pre- rather than postsynaptic 
receptors (Brooks et al., 1992). Using K-Gluconate based intracellular 
solution, this low concentration of baclofen (1 μM) elicited three types 
of responses in SPNs tested (n = 32), characterized by the degree of 
change in membrane potential and input resistance. Thus the SPNs 
were grouped according to their responses into (i) a large-response 
group (37.5%) where both parameters were significantly altered by 
drug application (Figure 1A); (ii) a modest response group (34.4%) 
with small hyperpolarizations observed but no significant alteration in 
input resistance (Figure 1B); and (iii) a non-responding group (28.1%) 
where neither membrane potential nor input resistance of neurons 
were changed after bath application of baclofen (Figure 1C).
In the large-response group, the average change in cell membrane 
potential was −7.24 ± 0.9 mV associated with a decrease in input 
resistance to 87.6 ± 3% of control (612.7 ± 83 to 535.2 ± 72 MΩ, 
p < 0.005, n = 12). Responses were also maintained in the presence of 
1 μM external TTX (n = 3) and antagonized by the GABA
B
 receptor 
antagonist CGP55845 (mean hyperpolarization in baclofen alone 
was −8.9 ± 1.5 mV, mean hyperpolarization in baclofen + CGP55845 
was −0.2 ± 0.2 mV; p < 0.005, n = 5; Figure 3A and see also Wang et al., 
2008). An early study in SPNs also reported large hyperpolarizations 
associated with decreases in input resistance (Whyment et al., 2004) 
when using much higher concentrations of baclofen (10–100 μM) 
and suggested that this hyperpolarization was due to activation of 
GABA
B
 receptor coupled K conductances. The moderate response 
group only showed hyperpolarizations of −1.80 ± 2.4 mV (n = 11; 
Figure 1B) which were significantly smaller than the large response 
group (p < 0.001) and the input resistances of these cells were not 
significantly altered (597.6 ± 50 to 586.4 ± 49 MΩ). Non-responding 
cells were not affected by low concentrations of baclofen (average 
change in membrane potential was 0.24 ± 0.2 mV, n = 9; Figure 1C). 
A lower concentration (0.5 μM) also showed a similar grouping of 
responses (data not shown) to these observed with 1 μM baclofen 
but with smaller sample sizes.
Electrically coupled activities (observed as spikelets described 
by Logan et al., 1996; Nolan et al., 1999) were recorded from 10 of 
the 32 SPNs, where a strong degree of coupled activity was noted. 
These strongly coupled cells were equally distributed between the 
three subgroups (4, 4, 2, in three groups respectively). Coupled 
events in all four cells in the large-response group were completely 
abolished during drug application. In the moderate response group, 
baclofen completely blocked spikelets in 2/4 cells and left the other 
two partially reduced in frequency. In the non-responding group, 
without altering the membrane  properties of the recorded neurons, 
baclofen blocked the spikelets of one strongly coupled cell and 
reduced the frequency of the other (Figure 1C).
FiGure 1 | Postsynaptic responses to 1 mM baclofen differ in SPNs 
recorded in K-Gluconate based intracellular solution. (A) Bath application 
of baclofen induced hyperpolarization in this SPN, associated with a decrease 
in cell input resistance. (A1,A2) Pooled data (n = 12) showing membrane 
potential and input resistance changes before and during drug application. 
*p < 0.05, Student’s t-test. (B) Bath application of baclofen hyperpolarized this 
SPN slightly without changing cell input resistance. (B1,B2) Pooled data 
(n = 11) showing membrane potential and input resistance changes before 
and during drug application. (C) Bath application of baclofen did not induce any 
membrane potential or input resistance changes in this SPN. Expanded traces 
showing coupled activities (arrows) were reduced but not abolished during 
drug application. (C1,C2) Pooled data (n = 9) showing membrane potential and 
input resistance changes before and during drug application.
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PostsynaPtIc effects of low concentratIons of baclofen 
recorded In cs-based Intracellular solutIon
Cs loaded TEA containing intracellular solution was used to inter-
nally block K+ conductance. Therefore, any membrane potential 
changes due to opening of K+ channels associated with activation of 
GABA
B
 receptors should no longer be seen. TTX was also applied. Of 
the 18 neurons recorded, 50% were only slightly hyperpolarized to a 
mean value of −3.02 ± 0.3 mV (this is a significant change from con-
trol, p < 0.005; n = 9; Figure 2A) with no significant input resistance 
changes (346.0 ± 46 to 348.3 ± 46 MΩ), similar to that observed in 
the moderate response group with K-Gluconate based intracellular 
solution. Indeed there was no significant difference between these 
values and those moderate responses recorded in K-Gluconate, even 
though there were slight differences in liquid junction potentials 
between the two solutions. CGP55845 also antagonized the effects 
of baclofen with Cs-based intracellular solutions, similar to that 
observed with K-Gluconate containing electrodes (mean hyperpo-
larization to baclofen was −3.14 ± 0.5 mV, whilst in CGP + baclofen, 
the mean hyperpolarization was −0.02 ± 0.2 mV, n = 3; Figure 3B). 
The other SPNs did not respond to 1 μM baclofen application 
(Figure 2B; n = 9).
Of the 18 cells recorded, 13 were strongly coupled with their 
neighboring cells. In the non-responding group, bath applica-
tion of baclofen completely blocked all the spikelets in two cells 
and reduced the frequency of spikelets in one cell. Coupled 
activities from three other cells stayed unchanged. The remain-
ing two cells of the group only displayed occasional spikelets 
therefore were not compared. All coupled activities from the 
seven coupled cells of the small response group were abolished 
by baclofen application.
The effects of Ca2+-free solution or cadmium chloride (100 μM) 
was tested on baclofen responses using Cs-based intracellular solu-
tion. Both Ca2+-free solutions and CdCl
2
 significantly reduced the 
small hyperpolarizing effects of baclofen recorded in Cs intracel-
lular solution from −2.3 ± 0.2 to −0.3 ± 0.1 mV (p < 0.005, n = 8; 
Figure 2C) with the extent of the blockade in the two situations 
not significantly different.
PostsynaPtIc effects of low concentratIons of baclofen on 
Interneurons
In all five interneurons recorded using K-Gluconate based intracel-
lular solution, bath application of 1 μM baclofen elicited an average 
membrane potential change to −7.2 ± 0.9 mV (p < 0.005), associated 
with a decrease in input resistance from 596 ± 102 to 463 ± 102 MΩ 
(p < 0.05; Figure 4). This indicates an effect of baclofen on GABA
B
 
receptors in these cells. By comparing the input resistance changes 
of the two cell populations (large-response group of SPNs and 
interneurons), the decrease in input resistance induced by low con-
centration of baclofen in interneurons is significantly higher than 
that of SPNs in the IML (p < 0.05).
gabab subunIts are exPressed In the IMl of sPInal cord
To further verify the presence in the IML of the different 
subunits that may contribute to these effects, PCR was per-
formed on punches of IML from spinal cord tissue of the 
same age, and prepared in the same way, as that used in the 
electrophysiological experiments.
FiGure 2 | Low concentrations of baclofen elicit differential responses in 
neurons recorded in Cs-based intracellular solution. (A) Bath application of 
1 mM baclofen hyperpolarized this neuron without changing cell input resistance 
in the presence of 1 mM TTX. (A1,A2) Pooled data (n = 9) showing membrane 
potential and input resistance changes before and during drug application. 
*p < 0.05, Student’s t-test. (B) Bath application of baclofen did not induce any 
membrane potential or cell input resistance changes in this neuron. (B1,B2) 
Pooled data (n = 9) showing membrane potential and input resistance changes 
before and during drug application. (C). Moderate responses to baclofen 
recorded in Cs-based intracellular solution could be further reduced by bathing in 
Ca2+-free solution. Upper trace shows the response to baclofen in normal aCSF, 
lower trace (without negative current pulses eliciting hyperpolarizing responses) 
in the same neuron shows a lack of response in Ca2+-free solution.
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PCR analysis was performed on cDNA samples taken from the 
spinal cord and IML. Expression of all GABA
B
 subunits was observed 
in both the spinal cord and IML samples (n = 4; Figure 5), denoted 
by the presence of a single band corresponding to the predicted size 
of each subunit [B1a (319 bp), B1b (290 bp), B2 (319 bp)].
PresynaPtic effects of low concentrations of baclofen on 
GabaerGic synaPtic transmission
In addition to activating at postsynaptic sites, GABA
B
 receptors can 
also be present on presynaptic terminals as auto- or heteroreceptors. 
As presented above, blockade of potassium conductance with cesium 
eliminated the postsynaptic receptor mediated large response by 1 μM 
baclofen. Under these conditions, regardless of the membrane potential 
responses, which comprise either no effect or small hyperpolarizations, 
the whole-cell input resistance remains unchanged. Therefore with Cs 
intracellular solution, any alterations observed in evoked GABAergic 
IPSPs would likely be due to a presynaptic modulatory effect. A paired 
pulse stimulation protocol was used in both Lf and CAA monosynaptic 
GABAergic pathways in order to monitor the changes in PPR.
Figure 3 | Baclofen responses are antagonized by CgP55845. (A) Using 
K-Gluconate electrodes, baclofen elicited a hyperpolarization that was 
antagonized completely by the preincubation of CGP55845. (B) A similar 
antagonism of baclofen induced hyperpolarizations was observed using TEA/
Cs sulfate electrodes.
Figure 4 | interneurons also respond to 1 µM baclofen. (A) Bath 
application of baclofen hyperpolarized this interneuron associated with a 
decrease in cell input resistance (recorded with K-Gluconate based 
intracellular solution). (B,C) Pooled data (n = 4) showing membrane potential 
and input resistance changes before and during drug application. *p < 0.005, 
Student’s t-test.
Figure 5 | expression of gABAB subunits in the spinal cord and iML. 
GABAB receptor subunit mRNA expression in the spinal cord (left panel) and 
IML (right panel) is denoted by the presence of a single band corresponding to 
the predicted size of the subunits [B1a (319 bp), B1b (290 bp), B2 (319 bp)]. It 
is clear that at this age, all three subunits are expressed in the IML.
Bath application of 1 μM baclofen significantly reduced the peak 
amplitude of both CAA and Lf-IPSPs. The mean amplitudes of first 
IPSPs evoked via Lf stimulation were decreased to 75.4 ± 3.9% and 
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The sensitivity of evoked IPSPs to GABA
A
 receptor antagonists was 
examined after blocking polysynaptic transmission and ionotropic 
glutamate receptors by kynurenic acid. Consistent with previous stud-
ies (Deuchars et al., 1997, 2005; Brooke et al., 2004), both Lf- and 
CAA-IPSPs were reduced in amplitude after bath application of 10 μM 
bicuculline (data not shown). The sensitivity to a GABA
A
 receptor 
antagonist suggests the nature of these IPSPs to be GABAergic.
Spontaneous IPSPs were observed in two SPNs recorded. Bath 
application of 1 μM baclofen dramatically reduced the frequency of 
sIPSPs in both cells, leaving only a few detectable events (Figure 8). 
Further detailed analysis was not performed since the significant 
drug effect did not leave enough events to be compared. However, 
the spectacular decrease in the number of IPSPs also signifies a 
presynaptic site of action.
dIscussIon
There are two main observations from this study; firstly that acti-
vation of presynaptic GABA
B
 autoreceptors caused attenuation of 
inhibitory postsynaptic potentials elicited by both Lf and CAA path-
ways. This suggests that there are GABA
B
 autoreceptors located on 
the second IPSPs to 83.8 ± 3.9% of control values (p < 0.05, n = 11; 
Figure 6A). This decrease in amplitude was accompanied by a sig-
nificant increase in PPR from 1.02 ± 0.0 to 1.16 ± 0.0 (p < 0.05). 
In four of the cells in which baclofen effects on Lf-IPSPs were 
observed and fully recovered upon washout, the GABA
B
 receptor 
antagonist CGP55845 (200 nM) was then applied. Preincubation 
of CGP55845 alone had no effect on PPR (p > 0.1) or IPSP ampli-
tude (p > 0.1). No significant changes were observed after further 
addition of baclofen (Figure 6B). These results together indicate 
a presynaptic depression on Lf-IPSPs due to activation of GABA
B
 
autoreceptors. In the CAA pathway, baclofen decreased the peak 
amplitudes of the first and second CAA-IPSPs to 70.3 ± 5.2% and 
82.9 ± 9.4% (Figure 7A; p < 0.05) of control values, respectively 
with an increase in PPR (from 1.05 ± 0.1 to 1.28 ± 0.1, p < 0.05). 
The antagonist CGP55845 (200 nM) was used for incubation in 
four cells after recovery from the first application of baclofen. Bath 
application of CGP55845 alone had no significant effect on the 
amplitude or PPR of CAA-IPSPs. This preincubation antagonized 
the baclofen induced reduction in amplitudes and PPR facilitation 
(n = 4, p > 0.05; Figure 7B).
FiGure 6 | Baclofen decreases the amplitude of Lf-iPSPs elicited in SPNs 
via a presynaptic site of action. (A) Trace from a neuron with Lf-IPSPs elicited 
by paired pulse stimulation. Bath application of 1 mM baclofen reversibly 
decreased the amplitude of both Lf-IPSPs (average of 10 consecutive sweeps). 
Pooled data (n = 11) showing changes in the amplitude of Lf-IPSPs (A1) and 
paired pulse ratio (A2) before and during baclofen application. (B) Trace from a 
neuron with Lf-IPSPs elicited by paired pulse stimulation. Bath application of 
200 nM CGP55845 alone did not significantly change the amplitude of Lf-IPSPs 
(average of 10 consecutive sweeps). Pooled data (n = 4) showing changes in the 
amplitudes of Lf-IPSPs (B1) and paired pulse ratios (B2). Under control 
conditions, incubation of CGP55845 and further addition of baclofen. *p < 0.05, 
Student’s t-test.
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vesicle  priming (Sakaba and Neher, 2003) thus reducing 
 neurotransmitter release. In our study, IPSPs elicited from Lf 
and CAA were affected to a similar degree by both the agonist 
baclofen (at low concentrations) and a broad spectrum antago-
nist CGP55845, indicating that the regulation of the two path-
ways is mediated through GABA
B
 receptors with comparable 
pharmacological properties. GABA
B
 receptors are composed 
of two subunits (GABA
B1
 and GABA
B2
) that form functional 
heterodimers (Marshall et al., 1999) and GABA
B1
 subunits can 
be further divided into GABA
B1a
 and GABA
B1b
 (Kaupmann 
et al., 1997; Kaupmann et al., 1998). In fact evidence suggests 
that presynaptic GABA
B
 receptors are mainly comprised of 
GABA
B1a
/GABA
B2
 subunits (Billinton et al., 1999; Towers et al., 
2000), so pharmacological differences would be unexpected. 
Hippocampal studies have reported that presynaptic GABA
B
 
receptors with similar properties are located on both stratum 
radiatum and stratum oriens interneurons, whilst mGluR 
receptors are limited to synaptic inputs from stratum oriens 
interneurons (Poncer et al., 2000). This further supports the 
idea that presynaptic GABA
B
 receptors are quite homogenous. 
Stimulating within the CAA activates GABAergic interneurons 
terminals of both descending and local neurons influencing SPN 
activity. Secondly, very low concentrations of baclofen induced a 
number of responses in SPNs and also hyperpolarized  interneurons – 
differences in responses may be due to the second messenger systems 
mediating these responses.
PresynaPtIc ModulatIon by gabab autorecePtors
Bath application of the GABA
B
 receptor agonist baclofen decreased 
the amplitudes of evoked IPSPs in SPNs elicited from both 
GABAergic pathways. The reduction was accompanied by an 
increased PPR which indicates a presynaptic site of action, medi-
ated through an inhibition of GABA release. Preincubation of the 
antagonist CGP55845 attenuated the agonist induced effects. The 
likelihood that this was a presynaptic action was strengthened by 
the observation that the frequency of spontaneous IPSPs, where 
observed, was also reduced by baclofen.
The concept of GABA
B
 receptors serving as autoreceptors 
located at the GABAergic terminals in the CNS is well known. 
When activated, GABA
B
 receptors cause inhibition of high 
voltage sensitive calcium channels (Mintz and Bean, 1993; 
Poncer et al., 1997) or can have a direct effect on  synaptic 
FiGure 7 | Baclofen decreases the amplitude of CAA-iPSPs elicited in SPNs 
via a presynaptic site of action. (A) Trace from a neuron with CAA-IPSPs 
elicited by paired pulse stimulation. Bath application of 1 mM baclofen reversibly 
decreased the amplitude of CAA-IPSPs (average of 10 consecutive sweeps). 
Pooled data (n = 13) showing changes in amplitude of CAA-IPSPs (A1) and 
paired pulse ratio (A2) before and during baclofen application. (B) Trace from a 
neuron with CAA-IPSPs elicited by paired pulse stimulation. Bath application of 
200 nM CGP55845 alone did not significantly change the amplitude of 
CAA-IPSPs (average of 10 consecutive sweeps). (B1) Pooled data (n = 4) 
showing changes in the amplitudes of CAA-IPSPs (B1) and paired pulse ratio 
(B2). Under control conditions, incubation of CGP55845 and further addition of 
baclofen. *p < 0.05, Student’s t-test.
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located within this region (Deuchars et al., 2005) and this area 
receives dense descending inputs from the medial prefrontal 
cortex. This region of the cortex is a defined vasomotor center, 
contributing a hypotensive influence (Bacon and Smith, 1993) 
and this effect may be manifested through direct activation of 
these local inhibitory GABAergic interneurons in the spinal 
cord that consequently inhibit SPNs. LF stimulation activates 
direct descending inhibitory pathways from regions such as the 
rostral ventrolateral medulla (Miura et al., 1994; Deuchars et al., 
1997). Activation of presynaptic GABA
B
 receptors will reduce 
both the descending and local inhibitory influences on sympa-
thetic outflow, regardless of their source or their target SPN. It 
seems that the heterogeneity is observed with the postsynaptic, 
rather than the presynaptic receptors onto SPN.
PresynaPtIc gabab recePtors are not tonIcally actIvated
The possibility that autoreceptors can be tonically activated at 
GABAergic terminals onto SPNs was examined in this study. 
Preincubation of GABA
B
 receptor antagonist CGP55845 had no 
significant effect on evoked IPSPs from both pathways. Thus, the 
autoreceptors located at the GABAergic terminals innervating 
SPNs are unlikely to be stimulated by ambient GABA, even after 
synaptic release. Physiological stimulation of GABA
B
 receptors 
seems to require strong synaptic stimulation which suggests 
that high GABA releases are required to reach and thus stimu-
late the receptors (Isaacson et al., 1993; Scanziani, 2000). This 
is likely due to the efficient uptake systems in place to remove 
GABA since uptake inhibitors increase the likelihood of activa-
tion of the GABA
B
 receptors (Isaacson et al., 1993; Scanziani, 
2000). The absence of tonic GABA
B
 activation on SPNs has also 
been reported using a splanchnic nerve–spinal cord preparation 
(Cheng et al., 2005).
dIstInct PostsynaPtIc resPonses to low concentratIons of 
baclofen In sPns
Postsynaptic GABA
B
 receptors are predominantly coupled to G 
protein coupled inward rectifying potassium channels (GIRKs) and 
therefore cause an inhibitory effect on the cell by increasing K+ con-
ductance. However, not all SPNs exhibited a typical large response 
after challenge with low concentrations of baclofen. Indeed, many 
exhibited much smaller responses that were not accompanied by 
changes in input resistance. One possible explanation for the more 
moderate responses observed in some SPNs is that the SPN itself 
is not affected directly by GABA
B
 receptors located on its postsyn-
aptic membrane but that the hyperpolarization is mediated by an 
effect on neighboring SPNS that are coupled by gap junctions to 
the recorded neuron and this hyperpolarization is relayed through 
the gap junctions. However, in non-responding neurons, spikelets 
were also observed that were reduced or abolished by application 
of baclofen with no accompanying change in membrane potential. 
This therefore makes the theory of the moderate response being 
due to conduction of hyperpolarizing responses from neighboring 
neurons less likely, although it cannot be totally discounted since 
some spikelets do remain.
Our data demonstrate that these moderate hyperpolarizations 
to low concentrations of baclofen were observed in some SPNs 
whether recordings were made either in K+ based or Cs-based intra-
cellular solution. The moderate response is likely to be inhibition of 
voltage gated calcium channels since nominally Ca2+
 
free solution 
or cadmium further reduced this effect. This is similar to responses 
observed by (Cheng et al., 2005), who used higher concentrations of 
baclofen. We cannot rule out the possibility that the Ca2+ activated 
K+ channels contribute to the moderate response observed since 
these may not be blocked completely with the potassium blockers 
used, especially in more distal regions of the neuron where complete 
dialysis of the neuronal content is unlikely to be achieved. However 
in support of a role of calcium channels, recent studies (Vigot 
et al., 2006; Perez-Garci et al., 2006) using knockout mice (either 
1b−/− or 1a−/−) concluded that activation of GABA
B1(b)
 containing 
postsynaptic receptors directly blocks dendritic Ca2+ channels of 
layer 5 of cortical pyramidal neurons.
The distinct responses may reflect activation of different postsyn-
aptic receptor subtypes or association with distinct second messenger 
systems. Such a suggestion is supported by data from substantia nigral 
cells that showed GABA
B
 receptors linked to different GIRK chan-
nels (Koyrakh et al., 2005). Multiple subtypes of GABA
B
 receptors 
have been suggested after observing the effects of different selective 
antagonists (Solis and Nicoll, 1992; Cunningham and Enna, 1996). 
Moreover, two types of pharmacologically distinct receptors were 
used to explain the residual responses of thalamocortical neurons 
mediated by baclofen (Guyon and Leresche, 1995). In fact evidence 
suggests that it is the GABA
B1a/2
 complex that exhibits the greater 
sensitivity to low concentrations of baclofen in the hippocampus that 
may be due mainly to differences in the density of those receptors over 
GABA
B1b/2
 complexes, rather than differences in their affinity (Guetg 
et al., 2009). Thus hyperpolarizations observed during application of 
1 μM baclofen in some cells could be mediated through preferential 
activation of receptors present in a higher density. There are devel-
opmental changes in GABA
B
  receptor subunits since GABA
B1(a)
 is 
FiGure 8 | Baclofen decreases the frequency of spontaneous iPSPs in 
SPNs. An example from an SPN where bath application of 1 mM baclofen 
reversibly decreased the frequency of spontaneous IPSPs. Arrows indicate 
samples of synaptic events.
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 receptors have not been proven, the fact that hyperpolarization 
was only observed in some SPNs (and possibly all interneurons) of 
the IML when using low concentrations of agonist might suggest 
a physiological significance underlying these differences in sensi-
tivity. Indeed many previous studies examining characteristics of 
SPNs have reported differences in spontaneous activity (Spanswick 
and Logan, 1990), electrical coupling (Logan et al., 1996), other 
intrinsic membrane properties (Zimmerman and Hochman, 2010) 
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of SPN perhaps possessing specific GABA
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(McKenna and Schramm, 1984; Wu and Dun, 1992). This study 
provides evidence that activation of GABA
B
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presses GABAergic inhibitory transmission. The regulation of two 
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predominant during embryonic period and at birth whilst GABA
B1(b)
 
expression increases during the first postnatal month in the brain 
(Fritschy et al., 1994). Our PCR results show that all three subunits 
are in fact present at the age that we carried out the experiments, 
so absence of a subunit may not be a contributing factor to our 
findings. A detailed study of receptor subunit composition and sub-
cellular localization would provide first hand information to under-
stand whether they are related to the pharmacological distinctions 
observed. For example, GABA
B1(b)
 subunit containing receptors have 
been reported to be present extrasynaptically in cerebellar Purkinje 
cells (Fritschy et al., 1999), dorsal cochlear nucleus (Lujan et al., 2004) 
and hippocampal CA1 pyramidal neurons (Kulik et al., 2006).
functIonal sIgnIfIcance and conclusIon
The results of activation of GABA
B
 receptors in sympathetic regu-
lation are complicated and sometimes contradictory. Due to the 
multiple functions of GABA
B
 receptors, it is not surprising that 
different experimental protocols lead to completely different conclu-
sions. For example, intrathecal injection of baclofen in the thoracic 
spinal cord decreases cardiac sympathetic activity (Kim et al., 2000) 
whilst intracerebroventricular or intraperitoneal administration of 
baclofen leads to an increase in blood pressure and heart rate (Persson 
and Henning, 1980). In a spinal cord–splanchnic nerve preparation, 
bath application of baclofen suppresses splanchnic nerve activi-
ties possibly via two mechanisms: direct inhibition of membrane 
excitability by affecting K+ or Ca2+ currents and/or attenuation of 
excitatory synaptic events to SPNs (Cheng et al., 2005).
In this study, the effects of stimulation of postsynaptic recep-
tors and presynaptic autoreceptors in SPNs were studied. Although 
pharmacologically distinct subtypes of postsynaptic GABA
B
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